FFRct vs LINQ II Insertable Cardiac Monitor
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These tools are adjacent in their application within cardiology, both leveraging AI for diagnostic purposes. HeartFlow FFRct is designed for non-invasive diagnosis of coronary artery disease by analyzing CCTA scans, while the Medtronic LINQ II focuses on long-term, continuous monitoring of heart rhythms to detect arrhythmias. The selection of either tool depends entirely on the specific cardiac condition being investigated.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
HeartFlow FFRct Analysis is a non-invasive diagnostic tool for assessing coronary artery disease (CAD) by creating personalized 3D models of coronary arteries from CCTA scans to analyze blood flow and identify narrowing. In contrast, the Medtronic LINQ II is an insertable cardiac monitor designed for long-term, continuous heart rhythm monitoring to diagnose arrhythmias, including in pediatric patients aged two and older.
HeartFlow FFRct Analysis utilizes AI and computational fluid dynamics to process CCTA images, generating 3D models that provide fractional flow reserve (FFRct) values to assess the physiological impact of coronary blockages on blood flow. The Medtronic LINQ II employs AccuRhythmu2122 AI algorithms within an implanted device to enhance the accuracy of detecting and monitoring heart rhythms over an extended period.
HeartFlow FFRct Analysis is a non-invasive diagnostic tool that uses a standard CCTA scan, requiring no additional appointments or invasive procedures beyond the initial CT. The Medtronic LINQ II is an insertable cardiac monitor, which involves a minimally invasive subcutaneous implantation procedure to provide continuous monitoring.
FFRct Analysis provides a diagnostic assessment based on a single CCTA scan, offering a snapshot of coronary artery blood flow at the time of acquisition. The LINQ II offers continuous heart rhythm monitoring for up to 4.5 years, with data transmitted automatically via the MyCareLink Heartu2122 mobile app or MyCareLink Relayu2122 home communicator.